
Landos Biopharma (LABP) Earnings Dates & Reports
Landos Biopharma (LABP) Most Recent Earnings
Report DateMay 9, 2024
Period EndingQ1 2024
Est. EPS-$1
Actual EPS-$1.43
EarningsMiss
Landos Biopharma (LABP) Earnings
View the latest Landos Biopharma (LABP) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Landos Biopharma (LABP)
Order type
Buy in
Order amount
Est. shares
0 shares
Landos Biopharma (LABP) Earnings per Share (EPS) History
Signup for full accessBrowse free
Landos Biopharma (LABP) Latest Earnings
The value each LABP share was expected to gain vs. the value each share gained.
Landos Biopharma (LABP) reported its most recent earnings on May 9, 2024 for Q1 2024, posting earnings per share (EPS) of -$1.43. This exceeded analysts' expectations of -$1 by 43.00%, marking a Miss.
For comparison, Landos Biopharma reported EPS of -$0.90 in the same quarter last year.
The company is expected to announce its next earnings report on 05/09/2024, with analysts projecting an EPS of $0.
Landos Biopharma (LABP) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q1 2024May 9, 2024 | -$1.00 | -$1.43 | +43.00% | |
Q4 2023Mar 21, 2024 | -$0.91 | -$0.99 | +8.79% | |
Q3 2023Nov 9, 2023 | -$0.88 | -$0.94 | +6.82% | |
Q2 2023Aug 9, 2023 | -$1.10 | -$0.63 | -42.73% | |
Q1 2023May 12, 2023 | -$0.90 | -$0.90 | 0.00% | |
Landos Biopharma (LABP) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Landos Biopharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Mar 21, 2024 | — | — | — |
Nov 9, 2023 | — | — | — |
Aug 9, 2023 | — | — | — |
May 12, 2023 | — | — | — |
Landos Biopharma (LABP) Earnings FAQs
Landos Biopharma (LABP) last reported earnings on May 9, 2024 for Q1 2024, posting an EPS of -$1.43, which Miss the estimate of -$1 by 43.00%.
For Q1 2024, Landos Biopharma (LABP) reported an EPS of -$1.43, missing analysts' estimate of -$1 by 43.00%.
For Q1 2024, Landos Biopharma (LABP) Miss expectations with an actual EPS of -$1.43 vs. an estimated EPS of -$1.
Following the last earnings report on May 9, 2024, Landos Biopharma (LABP)'s stock price moved — from — to —.
The next Landos Biopharma (LABP) earnings call is scheduled for May. 9, 2024, where executives will discuss financial results and outlook.